Cat.#: ACPP-1322
| Despition | TRPM8 Blocking Peptide for Immunocompeition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
| ACPP-1036 | Recombinant Human ANGPTL7 Protein (6×His Tag) (AC1036) | 50 µg | inquiry |
| ACPP-1173 | Recombinant Human alpha Synuclein Protein (AC1173) | 50 µl | inquiry |
| ACPP-1150 | Synthetic Nanodisc Human TRPV1 Protein (AC1150) | 10 µg | inquiry |
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
| ACPP-1035 | Recombinant Mouse TNF Receptor II Protein (6×His Tag) (AC1035) | 50 µg | inquiry |
| ACPP-1724 | Human FGF13 Protein (AC1724) | 5 µg | inquiry |
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1633 | Human PTPS Protein (AC1633) | 5 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.